Serum antibody response to influenza A in children with Down syndrome

Completed

• Conditions: Down syndrome; trisomy 21; 10021460; 10047438

• Registration Number: NL-OMON34503
• Lead Sponsor: Jeroen Bosch Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 20

Inclusion Criteria

down syndrome
vaccination with Influenza A

Exclusion Criteria

immunodeficiency other than down syndrome
recent infections prior to blood sample collection
treatment with immunosuppressive drugs in last year prior to blood collection
history of oncological disease

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Specific anti-influenza A (subtype H1N1 and / or seasonal) antibody titers will<br /><br>be measured.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>not applicable.</p><br>